<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04181398</url>
  </required_header>
  <id_info>
    <org_study_id>Palomino</org_study_id>
    <nct_id>NCT04181398</nct_id>
  </id_info>
  <brief_title>Low Grade Inflammation in Childhood Obesity : an Independent Risk Factor for Endothelial Dysfunction</brief_title>
  <official_title>Low Grade Inflammation in Childhood Obesity : an Independent Risk Factor for Endothelial Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Eligible candidates will be recruited within the children with overweight and obesity having&#xD;
      a metabolic risk evaluation before treatment in the period 2006 and 2010 at the pediatric&#xD;
      clinic of the UZ Brussel In total 60 participants will be investigated. Firstly, 30&#xD;
      participating patients with initially elevated hsCRP will be selected at random ( following&#xD;
      the date of their initial investigation) and afterwards matched for age, BMI z-score, and&#xD;
      blood pressure with the same number of patients without initially elevated hCRP values&#xD;
&#xD;
      Data will be collected as follows:&#xD;
&#xD;
        -  questionnaires&#xD;
&#xD;
        -  clinical examination/ anthropometry&#xD;
&#xD;
        -  blood sample (hsCRP)&#xD;
&#xD;
        -  peripheral arterial tonometry (endoPAT)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obesity and overweight have become an important health burden in children and adolescents,&#xD;
      with 19% of all children between 5 and 18 years being either obese or overweight in Belgium.&#xD;
      Obesity and especially visceral adiposity early in life may contribute to the development of&#xD;
      cardiovascular disease at older age, as it shows tracking into adulthood and is be associated&#xD;
      with cardiovascular risk factors such as dyslipidemia, insulin resistance, arterial&#xD;
      hypertension and low grade inflammation, in a variable percentage.&#xD;
&#xD;
      Low grade inflammation, as assessed by hSCRP, was found to be present in 20.6 % and 19.8 % of&#xD;
      overweight children and adolescents. In adults, hSCRP levels between 1 and 3 mg/L and above 3&#xD;
      mg/L are considered coronary disease risk factors.&#xD;
&#xD;
      Endothelial dysfunction, know to precede the formation of atherosclerotic plaque, can be&#xD;
      assessed in a non-invasive manner in children by peripheral artery tonometry. Only few&#xD;
      studies have been performed in obese children with this bed-side technique, showing either&#xD;
      normal of a disturbed function, reflected by a lower reactive hyperemia index. The&#xD;
      association with low grade inflammation however was assessed in only one study. The&#xD;
      investigators hypothesize that in adolescents and young adults with a history of childhood&#xD;
      obesity a more disturbed endothelial function will be present in those with and /or current&#xD;
      elevated hSCRP value.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Observational cohort study without blinding or randomization.</intervention_model_description>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial cell function</measure>
    <time_frame>through study completion, an average of 1 year (measured once)</time_frame>
    <description>Reactive hyperemia index (RHI) measured by the EndoPAT device.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>hs CRP level</measure>
    <time_frame>through study completion, an average of 1 year (measured once)</time_frame>
    <description>The investigators also hypothesized that low grade inflammation, and thus a rise in hs-CRP, will be persistent overtime.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BMI z-score</measure>
    <time_frame>through study completion, an average of 1 year (measured once)</time_frame>
    <description>The researchers want to investigate the evolution of the level of the obesity of the participants over time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fat percentage by skin fold measurements</measure>
    <time_frame>through study completion, an average of 1 year (measured once)</time_frame>
    <description>The researchers want to investigate the evolution of the level of the obesity of the participants over time</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Obesity, Childhood</condition>
  <condition>Obesity</condition>
  <condition>Endothelial Dysfunction</condition>
  <condition>Cardiovascular Risk Factor</condition>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>Baseline high hs-CRP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Anthropometry:&#xD;
Actual Height and weight&#xD;
Calculated BMI from measured weight and height.&#xD;
Pubertal development (Tanner stage)&#xD;
Waist circumference&#xD;
Skin fold measurement (Triceps and Subscapular)&#xD;
Waist-to-height ratio.&#xD;
Blood pressure (mean of 3 measurements)&#xD;
Peripheral arterial tonometry&#xD;
Questionnaire&#xD;
Blood sample (hsCRP)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Baseline low hs-CRP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Anthropometry:&#xD;
Actual Height and weight&#xD;
Calculated BMI from measured weight and height.&#xD;
Pubertal development (Tanner stage)&#xD;
Waist circumference&#xD;
Skin fold measurement (Triceps and Subscapular)&#xD;
Waist-to-height ratio.&#xD;
Blood pressure (mean of 3 measurements)&#xD;
Peripheral arterial tonometry&#xD;
Questionnaire&#xD;
Blood sample (hsCRP)</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Anthropometry</intervention_name>
    <description>Actual Height and weight&#xD;
Calculated BMI from measured weight and height.&#xD;
Pubertal development (Tanner stage)&#xD;
Waist circumference&#xD;
Skin fold measurement (Triceps and Subscapular)&#xD;
Waist-to-height ratio will be calculated from measured height and waist circumference.</description>
    <arm_group_label>Baseline high hs-CRP</arm_group_label>
    <arm_group_label>Baseline low hs-CRP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Blood pressure</intervention_name>
    <description>Blood pressure will be measured using an oscillometric, electronic device (Mindray). The blood pressure will be measured 3 times; the first measurement will not be taken into account and the mean of the second and third measurement will be considered as the real blood pressure.</description>
    <arm_group_label>Baseline high hs-CRP</arm_group_label>
    <arm_group_label>Baseline low hs-CRP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Peripheral arterial tonometry</intervention_name>
    <description>The investigator will measure the pulse wave amplitude by using a finger plethysmograph (peripheral arterial tonometry). The investigator will use the EndoPAT device from Itamar Medical Ltd. At the end of the examination, the participants will be asked to give a VAS-score (Visual Analogue Pain scale).</description>
    <arm_group_label>Baseline high hs-CRP</arm_group_label>
    <arm_group_label>Baseline low hs-CRP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire</intervention_name>
    <description>General questionnaire on cardiovascular risk factors</description>
    <arm_group_label>Baseline high hs-CRP</arm_group_label>
    <arm_group_label>Baseline low hs-CRP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Blood sample</intervention_name>
    <description>Blood sample for hs-CRP</description>
    <arm_group_label>Baseline high hs-CRP</arm_group_label>
    <arm_group_label>Baseline low hs-CRP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 12-21 years at the moment of evaluation&#xD;
&#xD;
          -  BMI &gt; 1.3 Standard Deviation Score at the initial evaluation&#xD;
&#xD;
          -  Hs-CRP available at initial evaluation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute of chronic Infection at the time of the study visit&#xD;
&#xD;
          -  Be or have been a smoker of tabacco&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean De Schepper, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitair Ziekenhuis Brussel</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Inge Gies, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitair Ziekenhuis Brussel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital of Brussels</name>
      <address>
        <city>Brussels</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>August 8, 2019</study_first_submitted>
  <study_first_submitted_qc>November 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 29, 2019</study_first_posted>
  <last_update_submitted>May 3, 2021</last_update_submitted>
  <last_update_submitted_qc>May 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitair Ziekenhuis Brussel</investigator_affiliation>
    <investigator_full_name>Inge Gies</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Pediatric Obesity</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 18, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/98/NCT04181398/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

